Two best friends Marion and Marit are about to finish high school and in a world where status is everything, they learn that an innocent little joke can go viral and change their lives forever.
Masumiyet follows the story of Bahar, a married mother of two, whose life changes drastically after her 19-year-old daughter falls in love with a wrong man. Her daughter Ela's first love is not a college student her age, but her father's 35-year-old boss, who is about to marry someone else. Bahar, who is trying to save her daughter from this wrong relationship, can not prevent what will happen, no matter what she does. An event that occurs on the day of Ela's 19th birthday party, changes the lives of Bahar and that of her family forever!
Exit are based on the true stories of four men in their mid-30s who all made became multi millionaires before the age of thirty an. Attempting to escape from their obligations, expectations and families, they employ drugs, prostitutes, and their very own set of morals.
The Good Girls Club is a drama series that follows the capital's night, where sensuality and sex mix with politics, security, business and glamour, and which will accompany the story of 3 characters: the security guard, the owner and the new girl.
A club in the city center, known for its luxury, extraordinary women, sensuality, sophistication and above all confidentiality… and also for the sirloin steak. Frequented by politicians, businessmen, artists and football players, it invests in exclusivity and secrecy. It's a family business, managed in the old days, which offers its clients contact with beautiful, sophisticated, available and expensive women.
A luxury nightclub that is about to be the stage of a power war in Lisbon's night.
Three stories about the world of opioids collide: a drug trafficker arranges a multi-cartel Fentanyl smuggling operation between Canada and the U.S., an architect recovering from an OxyContin addiction tracks down the truth behind her son's involvement with narcotics, and a university professor battles unexpected revelations about his research employer, a drug company with deep government influence bringing a new "non-addictive" painkiller to market.